Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Wildiers

Showing results (11-20 of 337) with videos related to

Pageof 34
Sort By:
Cancer Treatment Reviews|September 18, 2024
Oral SERDs changing the scenery in hormone receptor positive breast cancer, a comprehensive reviewMathilde Gheysen, Kevin Punie, Hans Wildiers, et al.
The Lancet. Oncology|March 6, 2010
Taxanes and anthracyclines in early breast cancer: which first?Hans Wildiers, Kathleen Forceville, Robert Paridaens, et al.
International Journal of Women'S Health|October 17, 2012
Update on triple-negative breast cancer: prognosis and management strategiesOlivier Brouckaert, Hans Wildiers, Giuseppe Floris, et al.
Cancers|April 3, 2021
Cancer and Aging: Two Tightly Interconnected Biological ProcessesLieze Berben, Giuseppe Floris, Hans Wildiers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Why should results from metastatic trials no longer matter for early-stage disease?Anne-Sophie Dieudonné, Diether Lambrechts, Hans Wildiers, et al.
Annals of Translational Medicine|April 21, 2023
Can ADCs broaden the treatment landscape of metastatic ER+/HER2- breast cancer resistant to CDK4/6 inhibition?Karen Van Baelen, Christine Desmedt, Hans Wildiers, et al.
Cancer Nursing|August 5, 2021
Remote System for Daily Symptom Monitoring During Systemic Anticancer Treatment: Patient Acceptance, Usability, and ComplianceAnnemarie Coolbrandt, Kristof Muylaert, Evi Vandeneede, et al.
Cancer Treatment Reviews|February 2, 2016
Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task ForceL Biganzoli, M Aapro, Sibylle Loibl, et al.
Current Opinion in Oncology|October 9, 2008
Triple-negative breast cancerGert Stockmans, Karen Deraedt, Hans Wildiers, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2021
Real-time symptom management in the context of a remote symptom-monitoring system: prospective process evaluation and cross-sectional survey to explore clinical relevanceAnnemarie Coolbrandt, Kristof Muylaert, Evi Vandeneede, et al.
Pageof 34

Showing results (11-20 of 337) with videos related to

Sort By:
Pageof 34
Cancer Treatment Reviews|September 18, 2024
Oral SERDs changing the scenery in hormone receptor positive breast cancer, a comprehensive reviewMathilde Gheysen, Kevin Punie, Hans Wildiers, et al.
The Lancet. Oncology|March 6, 2010
Taxanes and anthracyclines in early breast cancer: which first?Hans Wildiers, Kathleen Forceville, Robert Paridaens, et al.
International Journal of Women'S Health|October 17, 2012
Update on triple-negative breast cancer: prognosis and management strategiesOlivier Brouckaert, Hans Wildiers, Giuseppe Floris, et al.
Cancers|April 3, 2021
Cancer and Aging: Two Tightly Interconnected Biological ProcessesLieze Berben, Giuseppe Floris, Hans Wildiers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Why should results from metastatic trials no longer matter for early-stage disease?Anne-Sophie Dieudonné, Diether Lambrechts, Hans Wildiers, et al.
Annals of Translational Medicine|April 21, 2023
Can ADCs broaden the treatment landscape of metastatic ER+/HER2- breast cancer resistant to CDK4/6 inhibition?Karen Van Baelen, Christine Desmedt, Hans Wildiers, et al.
Cancer Nursing|August 5, 2021
Remote System for Daily Symptom Monitoring During Systemic Anticancer Treatment: Patient Acceptance, Usability, and ComplianceAnnemarie Coolbrandt, Kristof Muylaert, Evi Vandeneede, et al.
Cancer Treatment Reviews|February 2, 2016
Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task ForceL Biganzoli, M Aapro, Sibylle Loibl, et al.
Current Opinion in Oncology|October 9, 2008
Triple-negative breast cancerGert Stockmans, Karen Deraedt, Hans Wildiers, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2021
Real-time symptom management in the context of a remote symptom-monitoring system: prospective process evaluation and cross-sectional survey to explore clinical relevanceAnnemarie Coolbrandt, Kristof Muylaert, Evi Vandeneede, et al.
Pageof 34